Early trial tests 'Living Drug' for Tough-to-Treat kidney autoimmunity
NCT ID NCT06557265
Summary
This early-stage study is testing the safety and early effectiveness of a new cell therapy called NKX019 for people with active lupus nephritis or primary membranous nephropathy, two serious autoimmune kidney diseases. Participants will receive a one-time treatment cycle involving chemotherapy followed by three infusions of the lab-modified immune cells. The main goal is to see if the treatment is safe and tolerable, while also looking for early signs that it can control the kidney disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nkarta Investigational Site
RECRUITINGLittle Rock, Arkansas, 72201, United States
Contact
-
Nkarta Investigational Site
RECRUITINGGainesville, Florida, 32610, United States
Contact
-
Nkarta Investigational Site
WITHDRAWNMiami, Florida, 33133, United States
-
Nkarta Investigational Site
RECRUITINGPlantation, Florida, 33317, United States
Contact
-
Nkarta Investigational Site
RECRUITINGTampa, Florida, 33602, United States
Contact
-
Nkarta Investigational Site
RECRUITINGAtlanta, Georgia, 30303, United States
Contact
-
Nkarta Investigational Site
RECRUITINGChicago, Illinois, 60612, United States
Contact
-
Nkarta Investigational Site
RECRUITINGNew Orleans, Louisiana, 70112, United States
Contact
-
Nkarta Investigational Site
RECRUITINGWorcester, Massachusetts, 01608, United States
Contact
-
Nkarta Investigational Site
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
-
Nkarta Investigational Site
RECRUITINGNew York, New York, 10007, United States
Contact
-
Nkarta Investigational Site
RECRUITINGStony Brook, New York, 11794, United States
Contact
-
Nkarta Investigational Site
RECRUITINGSyracuse, New York, 13202, United States
Contact
-
Nkarta Investigational Site
RECRUITINGDallas, Texas, 75201, United States
Contact
-
Nkarta Investigational Site
RECRUITINGHouston, Texas, 77002, United States
Contact
-
Nkarta Investigational Site
RECRUITINGManatí, 00674, Puerto Rico
Contact
Conditions
Explore the condition pages connected to this study.